Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity.
2021
Chimeric antigen receptor (CAR) T cell therapy is revolutionizing cancer immunotherapy for patients with B cell malignancies and is now being developed for solid tumors and chronic viral infections...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
83
References
1
Citations
NaN
KQI